Genopole allocates close to 30% of its budget to supporting research at the Évry-Corbeil site. With 20 academic laboratories under the aegis of major national research organisms and/or the University of Évry, Genopole is France’s leading biocluster in the fields of genomics, stem cells, gene therapy and synthetic biology.

At Genopole, researchers and research teams find the best possible conditions for launching their activities as well as opportunities to develop and valorize their results. The means available at Genopole include a dedicated oversight team, tools to ease laboratory arrivals, functional premises tailored to specific needs, assistance for strengthening competencies and acquiring equipment and access to a range of shared infrastructures, not to mention cutting-edge scientific events.

Genopole is rapidly enriching its research activities, in healthcare particularly, with, for example :
• a focus on innovative fields of research such as stem cells, gene therapy, synthetic biology, epigenomics ;
• the Clinical and Translational Research Center ;
• complete life sciences curriculums at the University of Évry-Val-d’Essonne ;
• advanced scientific infrastructures, a continuously growing family of businesses, and more.